157 results on '"Ashikaga T"'
Search Results
2. Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer
- Author
-
Ades, S., Kumar, S., Alam, M., Goodwin, A., Weckstein, D., Dugan, M., Ashikaga, T., Evans, M., Verschraegen, C., and Holmes, C.E.
- Published
- 2015
- Full Text
- View/download PDF
3. Robustness of Fisher's Linear Discriminant Function Under Two-Component Mixed Normal Models
- Author
-
Ashikaga, T. and Chang, P. C.
- Published
- 1981
- Full Text
- View/download PDF
4. Drug-coated balloon versus drug-eluting stent following orbital atherectomy for calcified coronary artery: one-year outcomes of a retrospective cohort study
- Author
-
Mitsui, K, primary, Lee, T, additional, Miyazaki, R, additional, Hara, N, additional, Nagamine, S, additional, Nakamura, T, additional, Terui, M, additional, Okata, S, additional, Nagase, M, additional, Nitta, G, additional, Watanabe, K, additional, Kaneko, M, additional, Nagata, Y, additional, Nozato, T, additional, and Ashikaga, T, additional
- Published
- 2021
- Full Text
- View/download PDF
5. Neurological outcome at 30-day as an estimator of 1-year functional status after out-of-hospital cardiac arrest with post-encephalopathy
- Author
-
Nitta, G, primary, Matsuda, J, additional, Kato, S, additional, Hada, Y, additional, Inaba, O, additional, Matsumura, Y, additional, Nozato, T, additional, Ashikaga, T, additional, and Sasano, T, additional
- Published
- 2021
- Full Text
- View/download PDF
6. Long-term prognostic factors of coronary artery disease patients after out-of-hospital cardiac arrest
- Author
-
Nitta, G, primary, Matsuda, J, additional, Lee, T, additional, Kato, S, additional, Hada, Y, additional, Inaba, O, additional, Matsumura, Y, additional, Nozato, T, additional, Ashikaga, T, additional, and Sasano, T, additional
- Published
- 2021
- Full Text
- View/download PDF
7. Pulsed methylprednisolone therapy markedly increases thrombin generation potential in a rabbit experiment: PB 4.69–5
- Author
-
Ashikaga, T, Yamashita, A, Muto, S, Nagae, C, Akita, M, Suzuki, N, Yamazaki, S, Takayama, S, and Taki, M
- Published
- 2013
8. Pathogenesis of hemostatic abnormalities due to L-asparaginase in children with acute leukemia: PB 1.61–1
- Author
-
Yamashita, A, Nagae, C, Ashikaga, T, Muto, S, Akita, M, Yamazaki, S, Takayama, S, Tatsunami, S, and Taki, M
- Published
- 2013
9. Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: results of an EAPCI survey
- Author
-
Adamo, Marianna, Byrne, Robert A., Baumbach, Andreas, Haude, Michael, Windecker, Stephan, Valgimigli, Marco, Aaroe, J., Abdeltawab, A. A., Accardi, R., Addad, F., Agostoni, P., Alajab, A., Alcázar, E., Alhabil, B., Altug Cakmak, H., Amico, F., Amoroso, G., Anderson, R., Andò, G., Andreou, A. Y., Antoniadis, D., Aquilina, M., Aramberry, L., Auer, J., Auffret, V., Ausiello, A., Austin, D., Avram, A., Ayman, E., Babunashvili, V., Bagur, R., Bakotic, Z., Balducelli, M., Ballesteros, S. M., Baptista, S., Baranauskas, A., Barbeau, G., Bax, M., Benchimol, C., Berroth, R., Biasco, L., Bilal, A., Binias, K., Blanco Mata, R., Boccuzzi, G., Bolognese, L., Boskovic, S., Bourboulis, N., Briguori, C., Bunc, M., Buysschaert, I., Calabro’, P., Campo, G., Candiello, A., Caprotta, U. F., Cardenas, M., Carrilho-Ferreira, P., Carrizo, S., Caruso, M., Cassar, A., Cernigliaro, C., Chacko, G., Chamie, D., Clapp, B., Coceani, M., Colangelo, S., Colombo, A., Comeglio, M., Connaughton, M., Conway, D., Cortese, B., Cosgrave, J., Costa, F., Couvoussis, E., Crimi, G., Crook, R., Cruz-Alvarado, J. E., Curello, S., D’Ascenzo, F., D’Urbano, M., Dana, A., De Backer, O., De Carlo, M., De Cesare, N., De Iaco, G., De La Torre, H. J. M., De Oliveira Netoj, B., Devlin, G. P., Di Lorenzo, E., Díaz, A., Dina, C., Dorsel, T. H., Eberli, F. R., Echeverría, R., Eftychiou, C., Elguindy, A., Ercilla, J., Ernst, A., Esposito, G., Ettori, F., Eufracino, Null, Ezquerra Aguilera, W., Falcone, C., Falu, R. M., Feres, F., Ferlini, M., Fernández, G., Fernández-Rodríguez, D., Fileti, L., Fischetti, D., Florescu, N., Formigli, D., Fouladvand, F., Franco, N., Fresco, C., Frigoli, E., Furmaniuk, J., Gabaldo, K., Galli, M., Galli, S., Garbo, R., Garducci, S., Garg, S., Gavrielatos, G., Gensch, J., Giacchi, G., Giunio, L., Giustino, G., Goldberg, L., Goldsmit, R., Gommeaux, A., González Godínez, H., Gosselin, G., Govorov, A., Grimfjard, P., Gross, E., Grosz, C., Guagliumi, G., Hadad, W., Hadadi, L., Hansen, P. R., Harb, S., Hatrick, R., Hayrapetyan, H. G., Hernández-Enríquez, M., Ho Heo, J., Horvath, I. G., Huan Loh, P., Ibrahim, A. M., Ierna, S., Ilic, I., Imperadore, F., Ionescu-Silva, E., Jacksch, R., James, S., Janiak, B., Jensen, S. E., Jeroen, S., Jugessur, R. K., Kala, P., Kambis, M., Kanakakis, J., Karamasis, G., Karchevsky, D., Karpovskiy, A., Kayaert, P., Kedev, S., Kemala, E., Ketteler, T., Khan, S. Q., Kharlamov, A., Kiernan, T., Kiviniem, T., Koltowski, L., Koskinas, K. C., Kouloumpinis, A., Kraaijeveld, A. O., Krizanic, F., Krötz, B., Kuczmik, W., Kukreja, N., Kuksa, D., Yav, K., Kyriakos, D., Labrunie, A., Laine, M., Lapin, O., Larosa, C., Latib, A., Lattuca, B., Lauer, B., Lefèvre, T., Legrand, V., Lehto, P., Leiva-Pons, J. L., Leone, A. M., Lev, G., Lim, R., Limbruno, U., Linares Vicente, J. A., Lindsay, S., Linnartz, C., Liso, A., Lluberas, R., Locuratolo, N., Lokshyn, S., Lunde, K., Lupi, A., Magnavacchi, P., Maia, F., Mainar, V., Mancone, M., Manolios, M. G., Mansour, S., Mariano, E., Marques, K., Martins, H., Mckenzie, D., Meco, S., Meemook, K., Mehmed, K., Melikyan, A., Mellwig, K. P., Mendiz, O. A., Merkulov, E., Mesquita, H. G., Mezzapelle, G., Miloradovic, V., Mohamed, S., Mohammed, B., Mohammed, F., Mohammed, K., Mohanad, A., Morawiec, B., More, R., Moreno-Martínez, F. L., Mrevlje, B., Muhammad, F., Näveri, H., Nazzaro, M. S., Neary, P., Negus, B. H., Nelson Durval, F. G., Nick, H., Nilva, E., Oldroyd, K. G., Olivares Asencio, C., Omerovic, E., Ortiz, M. A., Ota, H., Otasevic, P., Otieno, H. A., Paizis, I., Papp, E., Pasquetto, G., Patsourakos, N. G., Peels, J., Pelliccia, F., Pennacchi, M., Penzo, C., Perez, P., Perkan, A., Petrou, E., Phipathananunth, W., Pierri, A., Pinheiro, L. F., Pipa, J. L., Piva, T., Polad, J., Porto, I., Poveda, J., Predescu, L., Prog, R., Puri, R., Raco, D. L., Ramazan, O., Ramazzotti, V., Rao, S. V., Raungaard, B., Reczuch, K., Rekik, S., Rhouati, A., Rigattieri, S., Rodríguez-Olivares, R., Roik, M., Romagnoli, E., Román, A. J., Routledge, H., Rubartelli, P., Rubboli, A., Ruiz-García, J., Russo, F., Ruzsa, Z., Ryding, A., Saad, Aly, Sabate, M., Sabouret, P., Sadowski, M., Saia, F., Sanchez Perez, I., Santoro, G. M., Sarenac, D., Saririan, M., Sarma, J., Schuetz, T., Sciahbasi, A., Sebastian, M., Sebik, R., Sesana, M., Hur, Seung-Ho, Sganzerla, P., Shalva, R., Sharma, S., Sheiban, I., Shein, K. K., Shiekh, I. A., Sinha, M., Slhessarenko, J., Smith, D., Smyth, D. W., Sönmez, K., Sood, N., Sourgounis, A., Srdanovic, I., Stables, R. H., Stefanini, G. G., Stewart, J., Stoyanov, N., Suliman, A. A., Suryadevara, R., Suwannasom, P., Tange Veien, K., Tauchert, S., Tebet, M., Testa, L., Thury, A., Tilsted, H. H., Tiroch, K., Torres, A., Tosi, P., Traboulsi, M., Trani, C., Tresoldi, S., Tsigkas, G., Tueller, D., Turri, M., Udovichenko, A. E., Uretsky, B., Van Der Harst, P., Van Houwelingen, K. G., Vandoni, P., Vandormael, M., Varbella, F., Venkitachalam, C. G., Vercellino, M., Vidal-Perez, R., Vigna, C., Vignali, L., Vogt, F., Voudris, V., Vranckx, P., Vrolix, M., Vydt, T., Webster, M., Wijns, W., Woody, W., Wykrzykowska, J., Yazdani, S., Yildiz, A., Yurlevich, D., Zauith, R., Zekanovic, D., Zhao, M., Zimarino, M., Zingarelli, A., Abdelsamad, A. Y., Abo Shaera, E. S., Afshar, M. S., Agatiello, C., Aguiar, P., Ahmad, A. M., Akin, I., Alameda, M., Alegría-Barrero, E., Alejos, R., Alkhashab, K., Alkutshan, R. S. A., Almorraweh, A., Altnji, I., Alvarez Iorio, C., Anchidin, O., Angel, J., Antonopoulos, A., Apshilava, G., Arana, C., Ashikaga, T., Assomull, R., Atef, S. Z., Azmus, A. D., Azzalini, L., Azzouz, A., Baglioni, P., Bampas, G., Basil, M. P., Baumbach, A., Besh, D., Bhushan Sharm, A., Bien Hsien, H., Bihui, L., Bing-Chen, L., Biryukov, S., Blatt, A., Bocchi, E., Boghdady, A., Bonarjee, V. V. S., Bosnjak, I., Bravo Baptista, S., Brinckman, S. L., Buchter, B., Burzotta, F., Cacucci, M., Cagliyan, C. E., Calabrò, P., Cernetti, C., Chávez Mizraym, R., Choo, W. S., Choudhury, R., Cicco, N., Cisneros Clavijo, P., Çitaku, H., Collet, J. P., Consuegra-Sánchez, L., Conte, M., Corral, J. M., Damonte, A., Dangoisse, V., Dastani, M., Della Rosa, F., Deora, S., Devadathan, S., Dharma, S., Di Giorgio, A., Diez, J. L., Dinesha, B., Duplančić, D., El Behwashi, M. F., Elghawaby, H., Elshahawy, O., Eskola, M. J., Etman, A., Eun Gyu, L., Fabiano, L., Facta, A., Fan, Y., Fang-Yang, H., Farag, E., Fathi, Y., Fazeli, N., Federico, P., Fereidoun, M. Z., Fernandez-Nofrerias, E., Flensted Lassen, J., Flessas, D., Fouad, H., Franco-Pelaez, J. A., Fu, Q., Furtado, R., Gadepalli, R., Gallino, R., Gasparetto, V., Gentiletti, A., Gholoobi, A., Ghosh, A. K., Gkizas, S., Golchha, S. K., Goncharov, A., Gössl, M., Götberg, M., Greco, F., Grundeken, M. J., Gupta, D., Gupta, S., Guray, U., Hahalis, G., Hakim Vista, J., Hamid, M. A., Hammoudeh, A., Hasan, A. R. I., Hatsumura, F. E., Heintzen, M. P., Helal, T., Hetherington, S., Hewarathna, U. I., Hioki, H., Hissein, F., Ho-Ping, Y., Homs, S., Huber, K., Ibarra, F. M., Ielasi, A., Ipek, E., Jambunathan, R., Jamshidi, P., Jarrad, I., Javier, W., Jensen, J., Jimenez-Quevedo, P., Kalpak, O., Kan, J., Kanaan, T., Kao, D. H. M., Karamfiloff, K., Karegren, A., Karjalainen, P. P., Kasabov, R., Katsimagklis, G. D., Kaul, U., Khan, A., Kiemeneij, E., Kiviniemi, T., Kleiban, A., Komiyama, N., Konteva, M., Koshy, G., Krepsky, A. M., Kuljit, S., Kulkarni, P., Kumar, V., Kuznetsov, I., Lai, G., Lateef, M. A., Lawand, S., Le Hong, T., Lettieri, C., Levy, G., Lindvall, P., Maitra, A., Makowski, M., Mamas, M. A., Mandal, S. C., Mangalanandan, P., Marin, R., Mashhadi, M., Matsukage, T., Meier, B., Milosavljevic, B., Miro, S. S., Mitov, A., Moeriel, M., Moguel, R., Mohanty, A., Montalescot, G., Mörsdorf, W., Moscato, F., Muniz, A., Muraglia, S., Myć, J., Nada, A., Nair, P., Namazi, M. H., Naraghipour, F., Nguyen, Q. N., Nicosia, A., Nikas, D., Ober, M., Ocaranza-Sánchez, R., Olivecrona, G., Pahlajani, D., Pandey, B. P., Parma, A., Parma, R., Patsilinakos, S. P., Pattam, J., Peddi, S., Perez, P. R., Peruga, J. Z., Pescoller, F., Petrov, I., Piatti, L., Pico-Aracil, F., Pina, J., Piroth, Z., Popa, V., Pourbehi, M. R., Pradhan, A. K., Prida, X. E., Purohit, B. V., Pyun, W. B., Quang Hung, D., Rada, I., Rafizadeh, O., Rahman, M. A., Rai, L., Ramsewak, A., Ravindran, R., Rodriguez De Leiras, O. S., Rodríguez Esteban, M., Roque Figueira, H., Saket, A., Sakhov, O., Saktheeswaran, M. K., Salachas, A., Sallam, A., Sampaolesi, A., Samy, A., Sanchis, J., Santaera, O., Santarelli, A., Santharaj, W. S., Sarango, B., Satheesh, S., Schmitz, T., Schühlen, H., Seewoosagur, R., Segev, A., Seisembekov, V., Semitko, S., Sengottuvelu, G., Sepulveda Varela, P., Sethi, A., Sharma, A., Sharma, R. K., Shi, Hy., Şimşek, M. A., Siqueira, B., Skalidis, E., Slawin, J., Sorokhtey, L., Spaulding, C., Srinivas, B., Srinivasan, M., Stakos, D., Stefanini, G., Stojkovic, S., Tacoy, G., Tawade, M., Tiecco, F., Tondi, S., Torresani, E. M., Tousek, P., Tran, T., Trantalis, G., Triantafyllou, K., Trivedi, R., Trivisonno, A., Tsui, K. L., Türkoğlu, C., Tzung-Dau, W., Ueno, H., Urban, U., Uretsky, B. F., Uscumlic, A., Venugopal, V., Verney, R., Vilar, J. V., Villacorta, V. G., Vishwanath, R., Vlachojannis, G. J., Vlachojannis, M., Vlad, V., Von Birgelen, C., Vukcevic, V., Wahab, A., Waksman, R., Wei-Wen, L., Weisz, G., Whittaker, A., Yadav, A., Yokoi, Y., Zacharoulis, A., Zahran, M., Zamani, J., Ziakas, A., Zimmermann, J. P., Adamo, M., Byrne, R. A., Baumbach, A., Haude, M., Windecker, S., Valgimigli, M., Aaroe, J., Abdeltawab, A. A., Accardi, R., Addad, F., Agostoni, P., Alajab, A., Alcazar, E., Alhabil, B., Altug Cakmak, H., Amico, F., Amoroso, G., Anderson, R., Ando, G., Andreou, A. Y., Antoniadis, D., Aquilina, M., Aramberry, L., Auer, J., Auffret, V., Ausiello, A., Austin, D., Avram, A., Ayman, E., Babunashvili, V., Bagur, R., Bakotic, Z., Balducelli, M., Ballesteros, S. M., Baptista, S., Baranauskas, A., Barbeau, G., Bax, M., Benchimol, C., Berroth, R., Biasco, L., Bilal, A., Binias, K., Blanco Mata, R., Boccuzzi, G., Bolognese, L., Boskovic, S., Bourboulis, N., Briguori, C., Bunc, M., Buysschaert, I., Calabro', P., Campo, G., Candiello, A., Caprotta, U. F., Cardenas, M., Carrilho-Ferreira, P., Carrizo, S., Caruso, M., Cassar, A., Cernigliaro, C., Chacko, G., Chamie, D., Clapp, B., Coceani, M., Colangelo, S., Colombo, A., Comeglio, M., Connaughton, M., Conway, D., Cortese, B., Cosgrave, J., Costa, F., Couvoussis, E., Crimi, G., Crook, R., Cruz-Alvarado, J. E., Curello, S., D'Ascenzo, F., D'Urbano, M., Dana, A., De Backer, O., De Carlo, M., De Cesare, N., De Iaco, G., De La Torre, H. J. M., De Oliveira Netoj, B., Devlin, G. P., Di Lorenzo, E., Diaz, A., Dina, C., Dorsel, T. H., Eberli, F. R., Echeverria, R., Eftychiou, C., Elguindy, A., Ercilla, J., Ernst, A., Esposito, G., Ettori, F., Eufracino, Ezquerra Aguilera, W., Falcone, C., Falu, R. M., Feres, F., Ferlini, M., Fernandez, G., Fernandez-Rodriguez, D., Fileti, L., Fischetti, D., Florescu, N., Formigli, D., Fouladvand, F., Franco, N., Fresco, C., Frigoli, E., Furmaniuk, J., Gabaldo, K., Galli, M., Galli, S., Garbo, R., Garducci, S., Garg, S., Gavrielatos, G., Gensch, J., Giacchi, G., Giunio, L., Giustino, G., Goldberg, L., Goldsmit, R., Gommeaux, A., Gosselin, G., Govorov, A., Gonzalez Godinez, H., Gross, E., Grosz, C., Guagliumi, G., Hadad, W., Hadadi, L., Hansen, P. R., Harb, S., Hatrick, R., Hayrapetyan, H. G., Hernandez-Enriquez, M., Ho Heo, J., Horvath, I. G., Huan Loh, P., Ibrahim, A. M., Ierna, S., Ilic, I., Imperadore, F., Ionescu-Silva, E., Jacksch, R., James, S., Janiak, B., Jensen, S. E., Jeroen, S., Jugessur, R. K., Kala, P., Kambis, M., Kanakakis, J., Karamasis, G., Karchevsky, D., Karpovskiy, A., Kayaert, P., Kedev, S., Kemala, E., Ketteler, T., Khan, S. Q., Kharlamov, A., Kiernan, T., Kiviniem, T., Koltowski, L., Koskinas, K. C., Kouloumpinis, A., Kraaijeveld, A. O., Krizanic, F., Krotz, B., Kuczmik, W., Kukreja, N., Kuksa, D., Yav, K., Kyriakos, D., Labrunie, A., Laine, M., Lapin, O., Larosa, C., Latib, A., Lattuca, B., Lauer, B., Lefevre, T., Legrand, V., Lehto, P., Leiva-Pons, J. L., Leone, A. M., Lev, G., Lim, R., Limbruno, U., Linares Vicente, J. A., Lindsay, S., Linnartz, C., Liso, A., Lluberas, R., Locuratolo, N., Lokshyn, S., Lunde, K., Lupi, A., Magnavacchi, P., Maia, F., Mainar, V., Mancone, M., Manolios, M. G., Mansour, S., Mariano, E., Marques, K., Martins, H., Mckenzie, D., Meco, S., Meemook, K., Mehmed, K., Melikyan, A., Mellwig, K. P., Mendiz, O. A., Merkulov, E., Mesquita, H. G., Mezzapelle, G., Miloradovic, V., Mohamed, S., Mohammed, B., Mohammed, F., Mohammed, K., Mohanad, A., Morawiec, B., More, R., Moreno-Martinez, F. L., Mrevlje, B., Muhammad, F., Naveri, H., Nazzaro, M. S., Neary, P., Negus, B. H., Nelson Durval, F. G., Nick, H., Nilva, E., Oldroyd, K. G., Olivares Asencio, C., Omerovic, E., Ortiz, M. A., Ota, H., Otasevic, P., Otieno, H. A., Paizis, I., Papp, E., Pasquetto, G., Patsourakos, N. G., Peels, J., Pelliccia, F., Pennacchi, M., Penzo, C., Perez, P., Perkan, A., Petrou, E., Phipathananunth, W., Pierri, A., Pinheiro, L. F., Pipa, J. L., Piva, T., Polad, J., Porto, I., Poveda, J., Predescu, L., Prog, R., Puri, R., Raco, D. L., Ramazan, O., Ramazzotti, V., Rao, S. V., Raungaard, B., Reczuch, K., Rekik, S., Rhouati, A., Rigattieri, S., Rodriguez-Olivares, R., Roik, M., Romagnoli, E., Roman, A. J., Routledge, H., Rubartelli, P., Rubboli, A., Ruiz-Garcia, J., Russo, F., Ruzsa, Z., Ryding, A., Saad, A., Sabate, M., Sabouret, P., Sadowski, M., Saia, F., Sanchez Perez, I., Santoro, G. M., Sarenac, D., Saririan, M., Sarma, J., Schuetz, T., Sciahbasi, A., Sebastian, M., Sebik, R., Sesana, M., Hur, S. -H., Sganzerla, P., Shalva, R., Sharma, S., Sheiban, I., Shein, K. K., Shiekh, I. A., Sinha, M., Slhessarenko, J., Smith, D., Smyth, D. W., Sonmez, K., Sood, N., Sourgounis, A., Srdanovic, I., Stables, R. H., Stefanini, G. G., Stewart, J., Stoyanov, N., Suliman, A. A., Suryadevara, R., Suwannasom, P., Tange Veien, K., Tauchert, S., Tebet, M., Testa, L., Thury, A., Tilsted, H. H., Tiroch, K., Torres, A., Tosi, P., Traboulsi, M., Trani, C., Tresoldi, S., Tsigkas, G., Tueller, D., Turri, M., Udovichenko, A. E., Uretsky, B., Van Der Harst, P., Van Houwelingen, K. G., Vandoni, P., Vandormael, M., Varbella, F., Venkitachalam, C. G., Vercellino, M., Vidal-Perez, R., Vigna, C., Vignali, L., Vogt, F., Voudris, V., Vranckx, P., Vrolix, M., Vydt, T., Webster, M., Wijns, W., Woody, W., Wykrzykowska, J., Yazdani, S., Yildiz, A., Yurlevich, D., Zauith, R., Zekanovic, D., Zhao, M., Zimarino, M., Zingarelli, A., Abdelsamad, A. Y., Abo Shaera, E. S., Afshar, M. S., Agatiello, C., Aguiar, P., Ahmad, A. M., Akin, I., Alameda, M., Alegria-Barrero, E., Alejos, R., Alkhashab, K., Alkutshan, R. S. A., Almorraweh, A., Altnji, I., Alvarez Iorio, C., Anchidin, O., Angel, J., Antonopoulos, A., Apshilava, G., Arana, C., Ashikaga, T., Assomull, R., Atef, S. Z., Azmus, A. D., Azzalini, L., Azzouz, A., Baglioni, P., Bampas, G., Basil, M. P., Besh, D., Bhushan Sharm, A., Bien Hsien, H., Bihui, L., Bing-Chen, L., Biryukov, S., Blatt, A., Bocchi, E., Boghdady, A., Bonarjee, V. V. S., Bosnjak, I., Bravo Baptista, S., Brinckman, S. L., Buchter, B., Burzotta, F., Cacucci, M., Cagliyan, C. E., Cernetti, C., Chavez Mizraym, R., Choo, W. S., Choudhury, R., Cicco, N., Cisneros Clavijo, P., Citaku, H., Collet, J. P., Consuegra-Sanchez, L., Conte, M., Corral, J. M., Damonte, A., Dangoisse, V., Dastani, M., Della Rosa, F., Deora, S., Devadathan, S., Dharma, S., Di Giorgio, A., Diez, J. L., Dinesha, B., Duplancic, D., El Behwashi, M. F., Elghawaby, H., Elshahawy, O., Eskola, M. J., Etman, A., Eun Gyu, L., Fabiano, L., Facta, A., Fan, Y., Fang-Yang, H., Farag, E., Fathi, Y., Fazeli, N., Federico, P., Fereidoun, M. Z., Fernandez-Nofrerias, E., Flensted Lassen, J., Flessas, D., Fouad, H., Franco-Pelaez, J. A., Fu, Q., Furtado, R., Gadepalli, R., Gallino, R., Gasparetto, V., Gentiletti, A., Gholoobi, A., Ghosh, A. K., Gkizas, S., Golchha, S. K., Goncharov, A., Gossl, M., Gotberg, M., Greco, F., Grundeken, M. J., Gupta, D., Gupta, S., Guray, U., Hahalis, G., Hakim Vista, J., Hamid, M. A., Hammoudeh, A., Hasan, A. R. I., Hatsumura, F. E., Heintzen, M. P., Helal, T., Hetherington, S., Hewarathna, U. I., Hioki, H., Hissein, F., Ho-Ping, Y., Homs, S., Huber, K., Ibarra, F. M., Ielasi, A., Ipek, E., Jambunathan, R., Jamshidi, P., Jarrad, I., Javier, W., Jensen, J., Jimenez-Quevedo, P., Kalpak, O., Kan, J., Kanaan, T., Kao, D. H. M., Karamfiloff, K., Karegren, A., Karjalainen, P. P., Kasabov, R., Katsimagklis, G. D., Kaul, U., Khan, A., Kiemeneij, E., Kiviniemi, T., Kleiban, A., Komiyama, N., Konteva, M., Koshy, G., Krepsky, A. M., Kuljit, S., Kulkarni, P., Kumar, V., Kuznetsov, I., Lai, G., Lateef, M. A., Lawand, S., Le Hong, T., Lettieri, C., Levy, G., Lindvall, P., Maitra, A., Makowski, M., Mamas, M. A., Mandal, S. C., Mangalanandan, P., Marin, R., Mashhadi, M., Matsukage, T., Meier, B., Milosavljevic, B., Miro, S. S., Mitov, A., Moeriel, M., Moguel, R., Mohanty, A., Montalescot, G., Morsdorf, W., Moscato, F., Muniz, A., Muraglia, S., Myc, J., Nada, A., Nair, P., Namazi, M. H., Naraghipour, F., Nguyen, Q. N., Nicosia, A., Nikas, D., Ober, M., Ocaranza-Sanchez, R., Olivecrona, G., Pahlajani, D., Pandey, B. P., Parma, A., Parma, R., Patsilinakos, S. P., Pattam, J., Peddi, S., Perez, P. R., Peruga, J. Z., Pescoller, F., Petrov, I., Piatti, L., Pico-Aracil, F., Pina, J., Piroth, Z., Popa, V., Pourbehi, M. R., Pradhan, A. K., Prida, X. E., Purohit, B. V., Pyun, W. B., Quang Hung, D., Rada, I., Rafizadeh, O., Rahman, M. A., Rai, L., Ramsewak, A., Ravindran, R., Rodriguez De Leiras, O. S., Rodriguez Esteban, M., Roque Figueira, H., Saket, A., Sakhov, O., Saktheeswaran, M. K., Salachas, A., Sallam, A., Sampaolesi, A., Samy, A., Sanchis, J., Santaera, O., Santarelli, A., Santharaj, W. S., Sarango, B., Satheesh, S., Schmitz, T., Schuhlen, H., Seewoosagur, R., Segev, A., Seisembekov, V., Semitko, S., Sengottuvelu, G., Sepulveda Varela, P., Sethi, A., Sharma, A., Sharma, R. K., Shi, Hy., Simsek, M. A., Siqueira, B., Skalidis, E., Slawin, J., Sorokhtey, L., Spaulding, C., Srinivas, B., Srinivasan, M., Stakos, D., Stojkovic, S., Tacoy, G., Tawade, M., Tiecco, F., Tondi, S., Torresani, E. M., Tousek, P., Tran, T., Trantalis, G., Triantafyllou, K., Trivedi, R., Trivisonno, A., Tsui, K. L., Turkoglu, C., Tzung-Dau, W., Ueno, H., Urban, U., Uretsky, B. F., Uscumlic, A., Venugopal, V., Verney, R., Vilar, J. V., Villacorta, V. G., Vishwanath, R., Vlachojannis, G. J., Vlachojannis, M., Vlad, V., Von Birgelen, C., Vukcevic, V., Wahab, A., Waksman, R., Wei-Wen, L., Weisz, G., Whittaker, A., Yadav, A., Yokoi, Y., Zacharoulis, A., Zahran, M., Zamani, J., Ziakas, A., Zimmermann, J. P., and Cardiology
- Subjects
Hirudin ,Percutaneous ,Antithrombin ,medicine.medical_treatment ,Psychological intervention ,030204 cardiovascular system & hematology ,medical ,0302 clinical medicine ,Peptide Fragment ,Surveys and Questionnaires ,Surveys and Questionnaire ,Medicine ,Bivalirudin ,030212 general & internal medicine ,Societies, Medical ,Transradial ,Anticoagulant ,Hirudins ,Middle Aged ,Recombinant Protein ,Recombinant Proteins ,Femoral Artery ,Radial Artery ,Cardiology ,acute coronary syndrome ,bivalirudin ,transradial ,adult ,antithrombins ,cardiology ,femoral artery ,hirudins ,humans ,middle aged ,peptide fragments ,percutaneous coronary intervention ,recombinant proteins ,societies, medical ,surveys and questionnaires ,attitude of health personnel ,radial artery ,Acute coronary syndrome ,Cardiology and Cardiovascular Medicine ,Human ,medicine.drug ,Adult ,medicine.medical_specialty ,Attitude of Health Personnel ,medicine.drug_class ,MEDLINE ,Antithrombins ,03 medical and health sciences ,societies ,Percutaneous Coronary Intervention ,Internal medicine ,Humans ,Acute Coronary Syndrome ,Peptide Fragments ,Management of acute coronary syndrome ,business.industry ,Percutaneous coronary intervention ,medicine.disease ,business - Abstract
AIMS Our aim was to report on a survey initiated by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) collecting the opinion of the cardiology community on the invasive management of acute coronary syndrome (ACS), before and after the MATRIX trial presentation at the American College of Cardiology (ACC) 2015 Scientific Sessions. METHODS AND RESULTS A web-based survey was distributed to all individuals registered on the EuroIntervention mailing list (n=15,200). A total of 572 and 763 physicians responded to the pre- and post-ACC survey, respectively. The radial approach emerged as the preferable access site for ACS patients undergoing invasive management with roughly every other responder interpreting the evidence for mortality benefit as definitive and calling for a guidelines upgrade to class I. The most frequently preferred anticoagulant in ACS patients remains unfractionated heparin (UFH), due to higher costs and greater perceived thrombotic risks associated with bivalirudin. However, more than a quarter of participants declared the use of bivalirudin would increase after MATRIX. CONCLUSIONS The MATRIX trial reinforced the evidence for a causal association between bleeding and mortality and triggered consensus on the superiority of the radial versus femoral approach. The belief that bivalirudin mitigates bleeding risk is common, but UFH still remains the preferred anticoagulant based on lower costs and thrombotic risks.
- Published
- 2016
- Full Text
- View/download PDF
10. Factor Xa generation in adult individuals: OC-MO-003
- Author
-
Brummel-Ziedins, K, Ashikaga, T, Orfeo, T, Gissel, M, Mann, K G, and Rosendaal, F R
- Published
- 2009
- Full Text
- View/download PDF
11. Topically Administered Acyclovir in the Treatment of Recurrent Herpes Simplex Genitalis: A Controlled Trial
- Author
-
Reichman, R. C., Badger, G. J., Guinan, M. E., Nahmias, A. J., Keeney, R. E., Davis, L. G., Ashikaga, T., and Dolin, R.
- Published
- 1983
12. Effect of Tumor Volume Doubling Time on Prognosis for Stage I Non–small Cell Lung Cancers
- Author
-
No, H., primary, Gagne, H.M., additional, Nelson, C.J., additional, Kinsey, M., additional, Garrison, G., additional, Kikut, J., additional, Gentchos, G., additional, Seward, D., additional, Sidiropoulos, N., additional, Folefac, E., additional, Leavitt, B., additional, Ashikaga, T., additional, Dragnev, K., additional, Lin, S.H., additional, and Anker, C.J., additional
- Published
- 2017
- Full Text
- View/download PDF
13. Poster session 1: Wednesday 3 December 2014, 09:00-16:00Location: Poster area
- Author
-
Tong, L., Huang, C., Ramalli, A., Tortoli, P., Luo, J., D'Hooge, J., Tzemos, N., Mordi, I., Bishay, T., Negishi, T., Hristova, K., Kurosawa, K., Bansal, M., Thavendiranathan, P., Yuda, S., Popescu, B., Vinereanu, D., Penicka, M., Marwick, T., Hamed, W., Kamel, M., Yaseen, R., El Barbary, H., Nemes, A., Kis, O., Gavaller, H., Kanyo, E., Forster, T., Angelis, A., Vlachopoulos, C., Ioakimidis, N., Felekos, I., Chrysohoou, C., Aznaouridis, K., Abdelrasoul, M., Terentes, D., Ageli, K., Stefanadis, C., Kurnicka, K., Domienik Karlowicz, J., Lichodziejewska, B., Goliszek, S., Grudzka, K., Krupa, M., Dzikowska Diduch, O., Ciurzynski, M., Pruszczyk, P., Capllonch, F. G., Ayerbe, J. L., Teis, A., Ferrer, E., Vallejo, N., Junca, G., Pla, R., Bayes Genis, A., Schwaiger, J., Knight, D., Gallimore, A., Schreiber, B., Handler, C., Coghlan, J., Bruno, R. M., Giardini, G., Malacrida, S., Catuzzo, B., Armenia, S., Brustia, R., Ghiadoni, L., Cauchy, E., Pratali, L., Kim, K., Lee, K., Cho, J., Yoon, H., Ahn, Y., Jeong, M., Park, J., Cho, S., Nastase, O., Enache, R., Mateescu, A., Botezatu, D., Ginghina, C., Gu, H., Sinha, M., Simpson, J., Chowienczyk, P., Fazlinezhad, A., Behesthi, A. T., Homaei, F., Mostafavi, H., Hosseini, G., Bakaeiyan, M., Boutsikou, M., Petrou, E., Dimopoulos, A., Dritsas, A., Leontiadis, E., Karatasakis, G., Sahin, S. T., Yurdakul, S., Yilmaz, N., Cengiz, B., Cagatay, Y., Aytekin, S., Yavuz, S., Karlsen, S., Dahlslett, T., Grenne, B., Sjoli, B., Smiseth, O., Edvardsen, T., Brunvand, H., Nasr, G., Nasr, A., Eleraki, A., Elrefai, S., Sonecki, P., Gustafsson, U., Naar, J., Stahlberg, M., Cerne, A., Capotosto, L., Rosato, Edoardo, D'Angeli, I., Azzano, A., Truscelli, G., Maio, M. D., Salsano, F., Terzano, C., Mangieri, E., Vitarelli, A., Renard, S., Najih, H., Mancini, J., Jacquier, A., Haentjens, J., Gaubert, J., Habib, G., Caminiti, G., D'Antoni, V., Cardaci, V., Conti, V., Volterrani, M., Ahn, J., Kim, D., Lee, H., Iliuta, L., Kim, S., Ryu, S., Ko, C., Pyun, Y., Yoon, S., Iudice, F. L., Esposito, R., Lembo, M., Santoro, C., Ballo, P., Mondillo, S., Simone, G. D., Galderisi, M., Hwang, Y., Kim, J., Moon, K., Yoo, K., Kim, C., Tagliamonte, E., Rigo, F., Cirillo, T., Caruso, A., Astarita, C., Cice, G., Quaranta, G., Romano, C., Capuano, N., Calabro', R., Zagatina, A., Zhuravskaya, N., Guseva, O., Huttin, O., Benichou, M., Voilliot, D., Venner, C., Micard, E., Girerd, N., Sadoul, N., Moulin, F., Juilliere, Y., Selton Suty, C., Baron, T., Christersson, C., Johansson, K., Flachskampf, F., Lee, S., Lee, J., Hur, S., Yun, J., Song, S., Kim, W., Ko, J., Nyktari, E., Bilal, S., Ali, S., Izgi, C., Prasad, S., Aly, M., Kleijn, S., Kandil, H., Kamp, O., Beladan, C., Calin, A., Rosca, M., Craciun, A., Gurzun, M., Calin, C., Mornos, C., Mornos, A., Ionac, A., Cozma, D., Crisan, S., Popescu, I., Ionescu, G., Petrescu, L., Camacho, S., Chulian, S. G., Carmona, R., Diaz, E., Giraldez, A., Gutierrez, A., Toro, R., Benezet, J., Antonini Canterin, F., Vriz, O., Carrubba, S. L., Poli, S., Leiballi, E., Zito, C., Careri, S., Caruso, R., Pellegrinet, M., Nicolosi, G., Kong, W., Kyu, K., Wong, R., Tay, E., Yip, J., Yeo, T., Poh, K., Correia, M., Delgado, A., Marmelo, B., Correia, E., Abreu, L., Cabral, C., Gama, P., Santos, O., Rahman, M., Borges, I. P., Peixoto, E., Peixoto, R., Marcolla, V., Okura, H., Kanai, M., Murata, E., Kataoka, T., Stoebe, S., Tarr, A., Pfeiffer, D., Hagendorff, A., Generati, G., Bandera, F., Pellegrino, M., Alfonzetti, E., Labate, V., Guazzi, M., Kuznetsov, V., Yaroslavskaya, E., Pushkarev, G., Krinochkin, D., Zyrianov, I., Carigi, S., Baldazzi, F., Bologna, F., Amati, S., Venturi, P., Grosseto, D., Biagetti, C., Fabbri, E., Arlotti, M., Piovaccari, G., Rahbi, H., Abdulhaq, A. B., Tleyjeh, I., Costantino, M., Tarsia, G., Innelli, P., Dores, E., Esposito, G., Matera, A., Trimarco, B., Mukred, K., Ashurov, R., Tanzilli, G., Merlo, M., Gigli, M., Stolfo, D., Pinamonti, B., Canterin, F. A., Muca, M., D'Angelo, G., Scapol, S., Nucci, M. D., Sinagra, G., Behaghel, A., Feneon, D., Fournet, M., Thebault, C., Martins, R., Mabo, P., Leclercq, C., Daubert, C., Donal, E., Pal, S. D., Chand, N. P., Sanjeev, A., Rajeev, M., Ankur, D., Gopal, S. R., Mzoughi, K., Zairi, I., Jabeur, M., Moussa, F. B., Chaabene, A. B., Kamoun, S., Mrabet, K., Fennira, S., Zargouni, A., Kraiem, S., Demkina, A., Hashieva, F., Krylova, N., Kovalevskaya, E., Potehkina, N., Zaroui, A., Said, R. B., Smaali, S., Rekik, B., Hlima, M. B., Mizouni, H., Mechmeche, R., Mourali, M., Malhotra, A., Sheikh, N., Dhutia, H., Siva, A., Narain, R., Merghani, A., Millar, L., Walker, M., Sharma, S., Papadakis, M., Siam Tsieu, V., Mansencal, N., Arslan, M., Deblaise, J., Dubourg, O., Boudiche, S., Larbi, N., Tababi, N., Hannachi, S., Chalbia, T., Halima, M. B., Boussada, R., Chistyakova, M. V., Govorin, A., Radaeva, E., Lipari, P., Bonapace, S., Valbusa, F., Rossi, A., Zenari, L., Lanzoni, L., Targher, G., Canali, G., Molon, G., Barbieri, E., Novo, G., Giambanco, S., Sutera, M., Bonomo, V., Giambanco, F., Rotolo, A., Evola, S., Assennato, P., Novo, S., Budnik, M., Piatkowski, R., Kochanowski, J., Opolski, G., Chatzistamatiou, E., Vagena, I. M., Manakos, K., Moustakas, G., Konstantinidis, D., Memo, G., Mitsakis, O., Kasakogias, A., Syros, P., Kallikazaros, I., Park, S., Kim, M., Shim, W., Marketou, M., Parthenakis, F., Kalyva, N., Pontikoglou, C., Maragkoudakis, S., Zacharis, E., Patrianakos, A., Maragoudakis, F., Papadaki, H., Vardas, P., Rodrigues, A., Perandini, L. A., Souza, T., Sa Pinto, A., Borba, E., Arruda, A., Furtado, M., Carvalho, F., Bonfa, E., Andrade, J., Hlubocka, Z., Malinova, V., Palecek, T., Danzig, V., Kuchynka, P., Dostalova, G., Zeman, J., Linhart, A., Trachanas, K., Vergi, N., Feretou, A., Corut, H., Sade, L. E., Ozin, B., Atar, I., Turgay, O., Muderrisoglu, H., Ledakowicz Polak, A., Polak, L., Krauza, G., Zielinska, M., Szulik, M., Streb, W., Wozniak, A., Lenarczyk, R., Sliwinska, A., Kalarus, Z., Kukulski, T., Nogueira, M., Branco, L., Agapito, A., Galrinho, A., Borba, A., Teixeira, P., Monteiro, A., Ramos, R., Cacela, D., Ferreira, R. C., Guala, A., Camporeale, C., Tosello, F., Canuto, C., Ridolfi, L., Traxanas, K., Marinov, R., Stamenov, G., Mihova, M., Persenska, S., Racheva, A., Plaskota, K., Trojnarska, O., Bartczak, A., Grajek, S., Bejiqi, R. R., Retkoceri, R., Bejiqi, H., Beha, A., Surdulli, S., Seya, M., Sasaoka, T., Hirasawa, K., Yoshikawa, S., Maejima, Y., Ashikaga, T., Hirao, K., Isobe, M., Dreyfus, J., Durand Viel, G., Cimadevilla, C., Brochet, E., Vahanian, A., Messika Zeitoun, D., Jin, C., Fang, F., Meng, F., Kam, K., Sun, J., Tsui, G., Wong, K., Wan, S., Yu, C., Lee, A., Cho, I. J., Chung, H., Heo, R., Ha, S., Hong, G., Shim, C., Chang, H., Ha, J., Chung, N., Moral, S., Gruosso, D., Galuppo, V., Teixido, G., Rodriguez Palomares, J., Gutierrez, L., Evangelista, A., Alexopoulos, A., Dawson, D., Nihoyannopoulos, P., Zainal, H. A., Ismail, J., Arshad, K., Ibrahim, Z., Lim, C., Rahman, E. A., Kasim, S., Peteiro, J., Barrio, A., Escudero, A., Bouzas Mosquera, A., Yanez, J., Martinez, D., Castro Beiras, A., Scali, M., Simioniuc, A., Mandoli, G., Lombardo, A., Massaro, F., Bello, V. D., Marzilli, M., Dini, F., Adachi, H., Tomono, J., Oshima, S., Ortega, G. M., Bustos, D. B., Garcia, R. L., Espino, A. S., Quinones, J. M., Ikuta, I., Lopez, M. R., Serrano, F. V., Gonzalez, J. B., Recio, M. G., Romano, G., D'Ancona, G., Pilato, G., Gesaro, G. D., Clemenza, F., Raffa, G., Scardulla, C., Sciacca, S., Lancellotti, P., Pilato, M., Addetia, K., Takeuchi, M., Maffessanti, F., Weinert, L., Hamilton, J., Mor Avi, V., Lang, R., Sugano, A., Seo, Y., Watabe, H., Kakefuda, Y., Aihara, H., Nishina, H., Ishizu, T., Fumikura, Y., Noguchi, Y., Aonuma, K., Luo, X., Shang, Q., Sammut, E. C., Chabinok, R., Jackson, T., Siarkos, M., Lee, L., Carr White, G., Rajani, R., Kapetanakis, S., Byrne, D., Walsh, J., Ellis, L., Mckiernan, S., Norris, S., King, G., Murphy, R., Katova, T., Simova, I., Kostova, V., Shuie, I., Ferferieva, V., Bogdanova, V., Castelon, X., Sasi, V., Domsik, P., Kalapos, A., Lengyel, C., Orosz, A., Grapsa, J., Demir, O., Sharma, R., Senior, R., Pilichowska, E., Zaborska, B., Baran, J., Stec, S., Kulakowski, P., Budaj, A., Herrera, J. E., Palacios, I. F., Mendoza, I., Marquez, J. A., Herrera, J. A., Octavio, J. A., Dempaire, G., Rotolo, M., Kosmala, W., Kaye, G., Saito, M., Negishi, K., Maceira, A. M., Ripoll, C., Cosin Sales, J., Igual, B., Salazar, J., Belloch, V., Dulai, R. S., Taylor, A., Gupta, S., and S. U. C., None
- Published
- 2014
14. Abstract S2-05: 10-yr follow-up results of occult detected sentinel node disease: NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients
- Author
-
Julian, TB, primary, Anderson, SJ, additional, Krag, DN, additional, Weaver, DL, additional, Costantino, JP, additional, Ashikaga, T, additional, Harlow, SP, additional, Mamounas, EP, additional, and Wolmark, N, additional
- Published
- 2013
- Full Text
- View/download PDF
15. Increasing androgen receptor gene CAG repeat are associated with improved response to clomiphene citrate: an exploratory sub-analysis of the pregnancy in polycystic ovary syndrome trial (PPCOS I)
- Author
-
Hurliman, A., primary, Casson, P., additional, Ashikaga, T., additional, Brown, S., additional, and Bates, G.W., additional
- Published
- 2013
- Full Text
- View/download PDF
16. Impact of smoking on coronary microcirculatory resistance in patients with coronary artery disease
- Author
-
Miyazaki, T., primary, Ohigashi, H., additional, Komura, M., additional, Kobayashi, K., additional, Ashikaga, T., additional, and Isobe, M., additional
- Published
- 2013
- Full Text
- View/download PDF
17. One-year outcome of patients with intermediate coronary lesions assessed by fractional flow reserve in addition to diagnostic coronary angiogram
- Author
-
Miyazaki, T., primary, Ohigashi, H., additional, Komura, M., additional, Kobayashi, K., additional, Ashikaga, T., additional, and Isobe, M., additional
- Published
- 2013
- Full Text
- View/download PDF
18. The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis.
- Author
-
Kucharekova, M., Hornix, M., Ashikaga, T., T'kint, S., Jongh, G.J. de, Schalkwijk, J., Kerkhof, P.C.M. van de, Valk, P.G.M. van der, Kucharekova, M., Hornix, M., Ashikaga, T., T'kint, S., Jongh, G.J. de, Schalkwijk, J., Kerkhof, P.C.M. van de, and Valk, P.G.M. van der
- Abstract
Item does not contain fulltext, BACKGROUND: New therapeutic approaches have to be considered in the treatment of irritant contact dermatitis (ICD). Recently, phosphodiesterase 4 (PDE-4) inhibitors have been introduced as nonsteroidal, antiinflammatory agents. These agents inhibit the secretion of the cytokines thought to be involved in the pathogenesis of ICD. We investigated the effect of a new selective PDE-4 inhibitor (cipamfylline) in human models using single and repeated exposures to an irritant in a blind, randomized pilot study with healthy volunteers. We compared the effect of cipamfylline ointment with a strong corticosteroid (betamethasone-17-valerate) and with a placebo ointment. METHODS: Ten volunteers were patch tested at four investigation sites with sodium dodecyl sulphate (1%) for 24 h. In a model that simulates chronic damage, 11 volunteers were patch tested with sodium dodecyl sulphate (0.2%) for 4 h daily for four consecutive days. The investigation sites were treated once a day with the above-mentioned agents. One site was left untreated. We used erythema scoring, measurements of transepidermal water loss (TEWL) and several immunohistochemical markers for epidermal proliferation and differentiation. RESULTS: Repeated application revealed that betamethasone-17-valerate caused a statistically significant reduction in erythema and TEWL compared to cipamfylline and placebo. We also observed a significant suppression of proliferating cells and cytokeratin 16 expression at sites treated with betamethasone compared to the other sites. In the model for acute ICD, no significant differences were seen between the investigated sites. CONCLUSIONS: Our results show that betamethasone-17-valerate may modulate the response in ICD. In this human model of ICD we could not confirm the efficacy of cipamfylline. Clinical studies are needed before the effect of PDE-4 inhibitors in ICD can be refuted with certainty.
- Published
- 2003
19. Field Evaluation of a New Sequential Sampling Technique for Determining Apple Scab “Risk”
- Author
-
Reardon, J. E., primary, Berkett, L. P., additional, Garcia, M. E., additional, Gotlieb, A., additional, Ashikaga, T., additional, and Badger, G., additional
- Published
- 2005
- Full Text
- View/download PDF
20. Novel motors and controllers for high-performance electric vehicle with four in-wheel motors
- Author
-
Terashima, M., primary, Ashikaga, T., additional, Mizuno, T., additional, Natori, K., additional, Fujiwara, N., additional, and Yada, M., additional
- Published
- 1997
- Full Text
- View/download PDF
21. Human papillomavirus (HPV) education in middle and high schools of Vermont.
- Author
-
Beatty BG, O'Connell M, Ashikaga T, and Cooper K
- Abstract
Human papillomavirus (HPV), the most prevalent sexually transmitted disease (STD), continues to pose a significant public health problem especially among the adolescent population. Most precancerous and cancerous cervical changes are associated with HPV, with adolescent women being biologically at highest risk for acquiring HPV. This survey examined the type of information taught to adolescents about HPV, and specific needs for effective HPV education in middle and high schools in Vermont. The survey addressed knowledge level, behavior, attitudes, enabling factors, motivators, and barriers. Data were analyzed by descriptive statistics and supplemented with contingency table analyses. Replies (n = 108) were received from 79 schools, with 60% of responses from nurses and 40% from teachers. In five of eight questions addressing basic knowledge of HPV, less than 60% of respondents gave the correct answer. Most (73%) felt it was important to teach about HPV relative to HIV/AIDS, but spent less classroom time teaching it. Main motivations for teaching about HPV were its importance, and a desire to increase student knowledge and prevention skills. Main barriers perceived were lack of time and materials and curricula, and need for more knowledge about HPV. The most prominent needs indicated included brochures for students, an increase in the educators' knowledge base, and a high school curriculum. Health educators in Vermont schools recognize the importance of teaching adolescents about HPV, but they lack basic knowledge and resources for teaching about HPV. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
22. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention.
- Author
-
Kabbani, S S, Watkins, M W, Ashikaga, T, Terrien, E F, Holoch, P A, Sobel, B E, and Schneider, D J
- Published
- 2001
23. Helping women quit smoking: results of a community intervention program.
- Author
-
Secker-Walker RH, Flynn BS, Solomon LJ, Skelly JM, Dorwaldt AL, and Ashikaga T
- Abstract
OBJECTIVES: This intervention was implemented to reduce the prevalence of cigarette smoking among women. METHODS: We used community organization approaches to create coalitions and task forces to develop and implement a multicomponent intervention in 2 counties in Vermont and New Hampshire, with a special focus on providing support to help women quit smoking. Evaluation was by pre-intervention and post-intervention random-digit-dialed telephone surveys in the intervention counties and the 2 matched comparison counties. RESULTS: In the intervention counties, compared with the comparison counties, the odds of a woman being a smoker after 4 years of program activities were 0.88 (95% confidence interval = 0.78, 1.00) (P = .02, 1-tailed); women smokers' perceptions of community norms about women smoking were significantly more negative (P = .002, 1-tailed); and the quit rate in the past 5 years was significantly greater (25.4% vs 21.4%; P = .02, 1-tailed). Quit rates were significantly higher in the intervention counties among younger women (aged 18 to 44 years); among women with household annual incomes of $25,000 or less; and among heavier smokers (those who smoked 25 or more cigarettes daily). CONCLUSIONS: In these rural counties, community participation in planning and implementing interventions was accompanied by favorable changes in women's smoking behavior. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
24. A model for health care delivery with an illustration of its application.
- Author
-
Vacek PM, Ashikaga T, Mabry JH, Vacek, P M, Ashikaga, T, Mabry, J H, and Brown, J P
- Published
- 1978
- Full Text
- View/download PDF
25. Medical information management: improving the transfer of research results to presurgical evaluation.
- Author
-
Chase, Christopher R., Vacek, Pamela M., Shinozaki, Tamotsu, Giard, Ann M., Ashikaga, Takamaru, Chase, C R, Vacek, P M, Shinozaki, T, Giard, A M, and Ashikaga, T
- Published
- 1983
26. Relation of regional fat distribution to insulin sensitivity in postmenopausal women - a controlled longitudinal study
- Author
-
Sites, C.K., Calles-Escandon, J., Brochu, M., Butterfield, M., Ashikaga, T., and Poehlman, E.T.
- Published
- 2000
- Full Text
- View/download PDF
27. Effect of short-term hormone replacement therapy on left ventricular mass and contractile function
- Author
-
Sites, C. K., Tischler, M. D., Blackman, J. A., Niggel, J., Fairbank, J. T., O'Connell, M., and Ashikaga, T.
- Published
- 1999
- Full Text
- View/download PDF
28. The ear lobe crease sign and coronary artery disease in aortic stenosis.
- Author
-
Gibson, T. C. and Ashikaga, T.
- Published
- 1986
- Full Text
- View/download PDF
29. Monte Carlo study of forward stepwise discrimination based on small samples
- Author
-
Costanza, M.C., primary and Ashikaga, T., additional
- Published
- 1986
- Full Text
- View/download PDF
30. Primary care physicians' use of family history for cancer risk assessment
- Author
-
Stockdale Alan, Ashikaga Takamaru, Wood Marie E, Flynn Brian S, Dana Greg S, and Naud Shelly
- Subjects
Medicine (General) ,R5-920 - Abstract
Abstract Background Family history (FH) assessment is useful in identifying and managing patients at increased risk for cancer. This study assessed reported FH quality and associations with physician perceptions. Methods Primary care physicians practicing in two northeastern U.S. states were surveyed (n = 880; 70% response rate). Outcome measures of FH quality were extent of FH taken and ascertaining age at cancer diagnosis for affected family members. Predictors of quality measured in this survey included: perceived advantages and disadvantages of collecting FH information, knowledge of management options, access to supportive resources, and confidence in ability to interpret FH. Results Reported collection of information regarding second degree blood relatives and age of diagnosis among affected relatives was low. All hypothesized predictors were associated with measures of FH quality, but not all were consistent independent predictors. Perceived advantages of taking a family history, access to supportive resources, and confidence in ability to identify and manage higher risk patients were independent predictors of both FH quality measures. Perceived disadvantages of taking a family history was independently associated one measure of FH quality. Knowledge of management options was not independently associated with either quality measure. Conclusions Modifiable perception and resource factors were independently associated with quality of FH taking in a large and diverse sample of primary care physicians. Improving FH quality for identification of high risk individuals will require multi-faceted interventions.
- Published
- 2010
- Full Text
- View/download PDF
31. Case Report: Drug-coated balloon after intravascular lithotripsy for the treatment of severely calcified de novo coronary artery lesion.
- Author
-
Misawa T, Lee T, Ashikaga T, Nozato T, Yonetsu T, and Sasano T
- Abstract
In patients undergoing percutaneous coronary intervention (PCI), severely calcified lesions remain a great challenge even in the drug-eluting stent (DES) era. Intravascular lithotripsy (IVL) is effective for modification of severely calcified lesions prior to DES implantation. However, the efficacy of PCI with drug-coated balloon (DCB) following IVL has not been fully elucidated. Here, we present a case of severely calcified de novo coronary artery lesion successfully underwent PCI with DCB following IVL under optical coherence tomography (OCT) guidance as well as mid-term follow-up OCT. DCB following IVL might be a potential revascularization strategy for patients with heavily calcified de novo coronary artery lesions., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (© 2024 Misawa, Lee, Ashikaga, Nozato, Yonetsu and Sasano.)
- Published
- 2024
- Full Text
- View/download PDF
32. A ruptured coronary artery aneurysm treated by covered stent implantation.
- Author
-
Terui MM, Ashikaga T, Nozato T, and Miyazaki R
- Abstract
Competing Interests: The authors have no conflicts of interest to declare.
- Published
- 2024
- Full Text
- View/download PDF
33. Evaluation of the immunotoxicity potential of nanomaterials using THP-1 cells.
- Author
-
Nishida A, Sawada Y, Arai R, Ishibashi N, Suzuo M, Ohno A, Ashikaga T, and Iijima K
- Abstract
With the expansion of nanomaterials (NMs) usage, concerns about their toxicity are increasing, and the wide variety of NMs makes it difficult to assess their toxicity. Therefore, the development of a high-throughput, accurate, and certified method to evaluate the immunotoxicity of NMs is required. In this study, we assessed the immunotoxicity potential of various NMs, such as nanoparticles of silver, silica, and titanium dioxide, using the human Cell Line Activation Test (h-CLAT) at the cellular level. After exposure to silver nanoparticle dispersions, the expression levels of CD86 and CD54 increased, suggesting the activation of antigen-presenting cells (APCs) by silver nanoparticles. Quantification of silver ions eluted from silver nanoparticles and the activation of APCs by silver ions suggested that it was due to the release of silver ions. Silica nanoparticles also increased the expression of CD86 and/or CD54, and their activation ability correlated with the synthesis methods and hydrodynamic diameters. The ability of titanium dioxide to activate APCs differed depending on the crystal type and hydrodynamic diameter. These results suggest a potential method to evaluate the immunotoxicity potential of various NMs based on their ability to activate APCs using human monocytic THP-1 cells. This method will be valuable in assessing the immunotoxicity potential and elucidating the immunotoxic mechanisms of NMs., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Nishida, Sawada, Arai, Ishibashi, Suzuo, Ohno, Ashikaga and Iijima.)
- Published
- 2024
- Full Text
- View/download PDF
34. Diagnosis and Prognostic Value of the Underlying Cause of Acute Coronary Syndrome in Optical Coherence Tomography-Guided Emergency Percutaneous Coronary Intervention.
- Author
-
Kondo S, Mizukami T, Kobayashi N, Wakabayashi K, Mori H, Yamamoto MH, Sambe T, Yasuhara S, Hibi K, Nanasato M, Sugiyama T, Kakuta T, Kondo T, Mitomo S, Nakamura S, Takano M, Yonetsu T, Ashikaga T, Dohi T, Yamamoto H, Kozuma K, Yamashita J, Yamaguchi J, Ohira H, Mitsumata K, Namiki A, Kimura S, Honye J, Kotoku N, Higuma T, Natsumeda M, Ikari Y, Sekimoto T, Matsumoto H, Suzuki H, Otake H, Sugizaki Y, Isomura N, Ochiai M, Suwa S, and Shinke T
- Subjects
- Humans, Coronary Vessels pathology, Prognosis, Prospective Studies, Retrospective Studies, Tomography, Optical Coherence methods, Acute Coronary Syndrome diagnostic imaging, Acute Coronary Syndrome epidemiology, Acute Coronary Syndrome therapy, Heart Failure complications, Percutaneous Coronary Intervention adverse effects, Plaque, Atherosclerotic pathology
- Abstract
Background The prognostic impact of optical coherence tomography-diagnosed culprit lesion morphology in acute coronary syndrome (ACS) has not been systematically examined in real-world settings. Methods and Results This investigator-initiated, prospective, multicenter, observational study was conducted at 22 Japanese hospitals to identify the prevalence of underlying ACS causes (plaque rupture [PR], plaque erosion [PE], and calcified nodules [CN]) and their impact on clinical outcomes. Patients with ACS diagnosed within 24 hours of symptom onset undergoing emergency percutaneous coronary intervention were enrolled. Optical coherence tomography-guided percutaneous coronary intervention recipients were assessed for underlying ACS causes and followed up for major adverse cardiac events (cardiovascular death, myocardial infarction, heart failure, or ischemia-driven revascularization) at 1 year. Of 1702 patients with ACS, 702 (40.7%) underwent optical coherence tomography-guided percutaneous coronary intervention for analysis. PR, PE, and CN prevalence was 59.1%, 25.6%, and 4.0%, respectively. One-year major adverse cardiac events occurred most frequently in patients with CN (32.1%), followed by PR (12.4%) and PE (6.2%) (log-rank P <0.0001), primarily driven by increased cardiovascular death (CN, 25.0%; PR, 0.7%; PE, 1.1%; log-rank P <0.0001) and heart failure trend (CN, 7.1%; PR, 6.8%; PE, 2.2%; log-rank P <0.075). On multivariate Cox regression analysis, the underlying ACS cause was associated with 1-year major adverse cardiac events (CN [hazard ratio (HR), 4.49 [95% CI, 1.35-14.89], P =0.014]; PR (HR, 2.18 [95% CI, 1.05-4.53], P =0.036]; PE as reference). Conclusions Despite being the least common, CN was a clinically significant underlying ACS cause, associated with the highest future major adverse cardiac events risk, followed by PR and PE. Future studies should evaluate the possibility of ACS underlying cause-based optical coherence tomography-guided optimization.
- Published
- 2023
- Full Text
- View/download PDF
35. Excimer Laser Coronary Angioplasty and Drug-Coated Balloon Treatment for Very Late Stent Thrombosis Due to Neoatherosclerosis as Assessed by Optical Coherence Tomography.
- Author
-
Kachi D, Lee T, Naito M, Matsuda K, Sayama K, Odanaka Y, Terui M, Horie T, Okata S, Nagase M, Taomoto Y, Misawa T, Miyazaki R, Kaneko M, Nagata Y, Nozato T, and Ashikaga T
- Subjects
- Humans, Angioplasty, Stents, Tomography, Optical Coherence, Lasers, Excimer therapeutic use
- Published
- 2023
- Full Text
- View/download PDF
36. Unique features of a foreign body seen after proximal optimisation technique following jailed balloon technique.
- Author
-
Terui MM, Ashikaga T, Nozato T, Miyazaki R, and Nagamine T
- Abstract
Competing Interests: The authors have no conflicts of interest to declare.
- Published
- 2023
- Full Text
- View/download PDF
37. Rationale and design of the TACTICS registry: Optical coherence tomography guided primary percutaneous coronary intervention for patients with acute coronary syndrome.
- Author
-
Yamamoto MH, Kondo S, Mizukami T, Yasuhara S, Wakabayashi K, Kobayashi N, Sambe T, Hibi K, Nanasato M, Sugiyama T, Kakuta T, Kondo T, Mitomo S, Nakamura S, Takano M, Yonetsu T, Ashikaga T, Dohi T, Yamamoto H, Kozuma K, Yamashita J, Yamaguchi J, Ohira H, Mitsumata K, Namiki A, Kimura S, Honye J, Kotoku N, Higuma T, Natsumeda M, Ikari Y, Sekimoto T, Mori H, Suzuki H, Otake H, Isomura N, Ochiai M, Suwa S, and Shinke T
- Subjects
- Humans, Tomography, Optical Coherence methods, Retrospective Studies, Prospective Studies, Coronary Angiography methods, Registries, Treatment Outcome, Coronary Vessels, Percutaneous Coronary Intervention adverse effects, Percutaneous Coronary Intervention methods, Acute Coronary Syndrome diagnostic imaging, Acute Coronary Syndrome etiology, Acute Coronary Syndrome therapy
- Abstract
Background: Recent retrospective investigations have suggested that optical coherence tomography (OCT) enables the diagnosis of underlying acute coronary syndrome (ACS) causes such as plaque rupture, plaque erosion, and calcified nodule. The relationships of these etiologies with clinical outcomes, and the clinical utility of OCT-guided primary percutaneous coronary intervention (PCI) are not systematically studied in real-world ACS treatment settings., Methods: The TACTICS registry is an investigator-initiated, prospective, multicenter, observational study to be conducted at 21 hospitals in Japan. A total of 700 patients with ACS (symptom onset within 24 h) undergoing OCT-guided primary PCI will be enrolled. The primary endpoint of the study is to identify the underlying causes of ACS using OCT-defined morphological assessment of the culprit lesion. The key secondary clinical endpoints are hazard ratios of the composite of cardiovascular death, non-fatal myocardial infarction, heart failure, or ischemia-driven revascularization in patients with underlying etiologies at the 12- and 24-month follow-ups. The feasibility of OCT-guided primary PCI for ACS will be assessed by the achievement rates of optimal post-procedural results and safety endpoints., Conclusion: The TACTICS registry will provide an overview of the underlying causes of ACS using OCT, and will reveal any difference in clinical outcomes depending on the underlying causes. The registry will also inform on the feasibility of OCT-guided primary PCI for patients with ACS., Competing Interests: Declaration of competing interest Masahiko Ochiai, lecture fee – Abbott Medical Japan LLC., Asahi Intecc, Boston Scientific, and Terumo; Hiromasa Otake, lecture fee - Abbott Medical Japan LLC. and Terumo; Toshiro Shinke, personal fees and research grant - Abbot Japan LLC. The rest of the authors have none to disclose., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
38. Pilot trial comparing COVID-19 publication database to conventional online search methods.
- Author
-
Torfs-Leibman C, Ashikaga T, Krag D, Lunna S, Robtoy S, and Bombardier R
- Subjects
- Humans, Pilot Projects, Online Systems, COVID-19
- Abstract
Background and Objectives: Literature review using search engines results in a list of manuscripts but does not provide the content contained in the manuscripts. Our goal was to evaluate user performance-based criteria of concept retrieval accuracy and efficiency using a new database system that contained information extracted from 1000 COVID-19 articles., Methods: A sample of 17 students from the University of Vermont were randomly assigned to use the COVID-19 publication database or their usual preferred search methods to research eight prompts about COVID-19. The relevance and accuracy of the evidence found for each prompt were graded. A Cox proportional hazards' model with a sandwich estimator and Kaplan-Meier plots were used to analyse these data in a time-to-correct answer context., Results: Our findings indicate that students using the new information management system answered significantly more prompts correctly and, in less time, than students using conventional research methods. Bivariate models for demographic factors indicated that previous research experience conferred an advantage in study performance, though it was found to be independent from the assigned research method., Conclusions: The results from this pilot randomised trial present a potential tool for more quickly and thoroughly navigating the literature on expansive topics such as COVID-19., Competing Interests: Competing interests: David Krag has a significant financial interest in Plomics Inc, the developer of RefBin.com. The investigator disclosed his personal financial interest to the IRB of the University of Vermont. The IRB at the University of Vermont and the University of Vermont Medical Center determined that this pilot study qualified for an exemption from ethics review. Any potential conflicts of interest were managed. All other authors declare that they have no conflicts of interest., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
39. Simple algorithm to narrow down the candidates to receive echocardiography in patients with chronic liver disease for suspected pulmonary hypertension.
- Author
-
Yamashita K, Kurosaki M, Nakanishi H, Tanaka Y, Ishido S, Inada K, Kirino S, Hayakawa Y, Matsumoto H, Nobusawa T, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Tamaki N, Yasui Y, Tsuchiya K, Takahashi Y, Miyazaki R, Ashikaga T, Enomoto N, and Izumi N
- Abstract
Aims: Portopulmonary hypertension (PoPH) is a subtype of pulmonary arterial hypertension related to portal hypertension. The definitive diagnosis of PoPH is made by invasive right heart catheterization. Alternatively, pulmonary arterial hypertension may be recognized noninvasively from the tricuspid regurgitant pressure gradient (TRPG), measured by echocardiography. In this study, we aimed to establish a simple algorithm to identify chronic liver disease patients with a high TRPG value in order to narrow down the candidates to receive echocardiography., Methods and Results: TRPG was measured by echocardiography in 152 patients with chronic liver disease. Factors predictive of TRPG >30 mmHg were investigated. There were 28 (18%) cases with TRPG >30 mmHg. Independent factors associated with a high TRPG were the presence of shortness of breath, high serum brain natriuretic peptide (BNP), and low serum albumin. Child-Pugh class or the presence of ascites, varices, or encephalopathy was not associated with TRPG. There was a correlation between the serum BNP and TRPG, and the optimal cutoff value of BNP by the Youden index was 122 pg/mL, and by 100% sensitivity was 50 pg/mL. A combination of these factors identified patients with a high probability of TRPG >30 mmHg ( n = 12, positive predictive value [PPV] of 83%), no probability ( n = 80, PPV 0%), and intermediate probability ( n = 60, PPV 25-34%). This algorithm has reduced the number of patients needing echocardiography by 53%., Conclusions: A simple algorithm using the presence of shortness of breath, serum BNP, and albumin levels can narrow down the candidates to receive echocardiography., (© 2022 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
40. Alcohol Consumption Is Associated With Postablation Recurrence but Not Changes in Atrial Substrate in Patients With Atrial Fibrillation: Insight from a High-Density Mapping Study.
- Author
-
Sagawa Y, Nagata Y, Miwa N, Yamaguchi T, Watanabe K, Kaneko M, Nakamura T, Nozato T, Ashikaga T, Goya M, and Sasano T
- Subjects
- Alcohol Drinking adverse effects, Electrophysiologic Techniques, Cardiac methods, Heart Atria, Humans, Recurrence, Treatment Outcome, Atrial Fibrillation diagnosis, Atrial Fibrillation surgery, Catheter Ablation adverse effects, Catheter Ablation methods
- Abstract
Background The association between alcohol consumption, atrial substrate, and outcomes after atrial fibrillation (AF) ablation remains controversial. This study evaluated the impacts of drinking on left atrial substrate and AF recurrence after ablation. Methods and Results We prospectively enrolled 110 patients with AF without structural heart disease (64±12 years) from 2 institutions. High-density left atrial electroanatomic mapping was performed using a high-density grid multipolar catheter. We investigated the impact of alcohol consumption on left atrial voltage, left atrial conduction velocity, and AF ablation outcome. Patients were classified as abstainers (<1 drink/wk), mild drinkers (1-7 drinks/wk), or moderate-heavy drinkers (>7 drinks/wk). High-density mapping (mean 2287±600 points/patient) was performed on 49 abstainers, 27 mild drinkers, and 34 moderate-heavy drinkers. Low-voltage zone and slow-conduction zone were identified in 39 (35%) and 54 (49%) patients, respectively. There was no significant difference in the proportions of low-voltage zone and slow-conduction zone among the 3 groups. The success rate after a single ablation was significantly lower in drinkers than in abstainers (79.3% versus 95.9% at 12 months; mean follow-up, 18±8 months; P =0.013). The success rate after a single or multiple ablations was not significantly different among abstainers and drinkers. In multivariate analysis, alcohol consumption ( P =0.02) and the presence of a low-voltage zone ( P =0.032) and slow-conduction zone ( P =0.02) were associated with AF recurrence after a single ablation, while low-voltage zone ( P =0.023) and slow-conduction zone ( P =0.024) were associated with AF recurrence after a single or multiple ablations. Conclusions Alcohol consumption was associated with AF recurrence after a single ablation but not changes in atrial substrate.
- Published
- 2022
- Full Text
- View/download PDF
41. Effectiveness and Safety of Direct Oral Anticoagulants vs. Warfarin and Recurrence After Discontinuation in Patients With Acute Venous Thromboembolism in the Real World.
- Author
-
Hara N, Lee T, Nozato T, Terui Matsuyama M, Okata S, Nagase M, Mitsui K, Nitta G, Watanabe K, Miyazaki R, Nagamine S, Kaneko M, Nakamura T, Nagata Y, Miyamoto T, Obayashi T, and Ashikaga T
- Subjects
- Administration, Oral, Anticoagulants therapeutic use, Hemorrhage chemically induced, Humans, Recurrence, Retrospective Studies, Warfarin therapeutic use, Venous Thromboembolism drug therapy, Venous Thromboembolism epidemiology, Venous Thrombosis drug therapy
- Abstract
Background: The efficacy of direct oral anticoagulants (DOACs) compared with warfarin for the treatment of venous thromboembolism (VTE), and the recurrence of VTE after discontinuation of anticoagulation therapy in research are limited., Methods and results: This retrospective study enrolled 893 patients with acute VTE between 2011 and 2019. The cohort was divided into the transient risk, unprovoked, continued cancer treatment, and cancer remission groups. The following were compared between DOACs and warfarin: composite outcome of all-cause death, VTE recurrence, bleeding and composite outcome of VTE-related death, recurrence and bleeding. In the continued cancer treatment group, more bleeding was seen in warfarin-treated patients than in patients treated with DOACs (53.2% vs. 31.2%, [P=0.048]). In addition, composite outcome of VTE-related death and recurrence after discontinuation of anticoagulation therapy (n=369) was evaluated. The continued cancer treatment group (multivariate analysis: HR: 3.62, 95% CI: 1.84-7.12, P<0.005) and bleeding-related discontinuation of therapy (HR: 2.60, 95% CI: 1.32-5.13, P=0.006) were independent predictors of the event after discontinuation of anticoagulation therapy. VTE recurrence after discontinuation of anticoagulation therapy in the cancer remission group was 1.6% and a statistically similar occurrence was found in the transient risk group (12.4%) (P=0.754)., Conclusions: DOACs may decrease bleeding incidence in patients continuing to receive cancer treatment. In patients with bleeding-related discontinuation of anticoagulation therapy, VTE recurrence may increase. Discontinuation of anticoagulant therapy might be a treatment option in patients who have completed their cancer treatment.
- Published
- 2022
- Full Text
- View/download PDF
42. Case Report: Importance of MRI Examination in the Diagnosis and Evaluation of COVID-19 mRNA Vaccination Induced Myocarditis: Our Experience and Literature Review.
- Author
-
Watanabe K, Ashikaga T, Maejima Y, Tao S, Terui M, Kishigami T, Kaneko M, Nakajima R, Okata S, Lee T, Horie T, Nagase M, Nitta G, Miyazaki R, Nagamine S, Nagata Y, Nozato T, Goya M, and Sasano T
- Abstract
Acute myocarditis is a rare but serious complication associated with mRNA-based coronavirus disease 2019 (COVID-19) vaccination. In this article, four COVID-19 mRNA vaccination induced myocarditis cases managed at our tertiary Medical Center have been discussed. Three patients had typical myocarditis. One patient suffered from atrioventricular block and heart failure, which required more intensive treatment, but eventually improved. Additionally, a review of cardiac magnetic resonance imaging (MRI) features related to the diagnosis of myocarditis showed that COVID-19 mRNA vaccine-associated myocarditis tend to have more late-gadolinium enhancement (LGE) accumulation in the inferior lateral wall direction. According to a report by the U.S. Centers for Disease Control and Prevention (CDC), the diagnosis of COVID-19 mRNA vaccine-associated myocarditis is based on clinical symptoms, altered myocardial enzymes, cardiac MRI finding, or histopathology. Cardiac MRI is relatively less invasive than myocardial biopsy and plays an important role in the diagnosis of myocarditis. This review may aid in the diagnosis of COVID-19 mRNA vaccine-associated myocarditis., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Watanabe, Ashikaga, Maejima, Tao, Terui, Kishigami, Kaneko, Nakajima, Okata, Lee, Horie, Nagase, Nitta, Miyazaki, Nagamine, Nagata, Nozato, Goya and Sasano.)
- Published
- 2022
- Full Text
- View/download PDF
43. β-Blockers Reduced the Target Lesion Revascularization After Percutaneous Coronary Intervention Using an Everolimus-eluting Stent.
- Author
-
Fujinami T, Ashikaga T, Hoshina K, Sasaoka T, Kurihara K, Yoshikawa S, Inagaki H, and Sasano T
- Subjects
- Adrenergic beta-Antagonists, Everolimus, Humans, Prosthesis Design, Risk Factors, Stents, Time Factors, Treatment Outcome, Coronary Artery Disease drug therapy, Coronary Artery Disease surgery, Drug-Eluting Stents, Percutaneous Coronary Intervention adverse effects
- Abstract
Background/aim: The effect of β-adrenergic blockers on everolimus-eluting stent (EES) implantation is unknown. We aimed to investigate how β-blockers affect the outcomes of EES by using the Tokyo-MD PCI registry data and analyse real-world data in this drug-eluting stent era in Japan., Patients and Methods: We selected 1,899 patients who underwent EES implantation. We compared patients with β-blocker administration versus those without, at follow-up regarding the incidence rate of ischemia-driven target lesion revascularization (ID-TLR), all-cause death, cardiac death, acute myocardial infarction (AMI), and stent thrombosis (ST)., Results: Patients in the β-blocker group had higher coronary risks than those in the non-β-blocker group. Although no significant difference was observed in the five-year incidence of all-cause death, cardiac death, AMI, and ST between the two groups, the incidence of ID-TLR was significantly lower in the β-blocker group (4.5% vs. 6.6%; p=0.04). β-Blocker administration (hazard ratio=0.61; p=0.016) was negatively associated with ID-TLR via multivariate analysis., Conclusion: β-Blocker administration reduced ID-TLR after percutaneous coronary intervention using an EES despite the greater comorbid risks and more severe disease lesions., (Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
44. Impact of the sinus node recovery time after termination of atrial fibrillation during catheter ablation on clinical outcomes in patients with persistent atrial fibrillation.
- Author
-
Watanabe K, Nagata Y, Nitta G, Okata S, Nagase M, Miyazaki R, Nagamine S, Kaneko M, Lee T, Nozato T, Ashikaga T, Goya M, and Sasano T
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Treatment Outcome, Sinoatrial Node physiopathology, Sinoatrial Node surgery, Time Factors, Atrial Fibrillation surgery, Atrial Fibrillation physiopathology, Catheter Ablation methods, Recurrence
- Abstract
Background: Although long sinus arrest is occasionally observed during atrial fibrillation (AF) catheter ablation when the fibrillation was terminated, its meaning and prognosis have not yet been clearly elucidated. We hypothesized that sinus node recovery time (SNRT) after termination of AF (time from termination of AF to the earliest sinus node activation) could reflect the extent of atrial remodeling, influencing the formation of non-pulmonary vein (non-PV) triggers and post-ablation outcomes., Method: The participants were 157 consecutive patients with persistent AF (male: 77.1%, age: 63.3±11.2 years) who underwent catheter ablation. We recorded SNRT after terminating AF by radiofrequency delivery or electrical cardioversion during the first ablation and evaluated the relationships between SNRT and atrial tachyarrhythmia recurrence and between SNRT and non-PV triggers after repeat ablation., Results: Forty-five patients (28.7%) experienced recurrence of atrial tachyarrhythmias. Patients with recurrence had longer SNRTs (1738 ms vs. 1394 ms, p = 0.012). In the multivariate logistic regression analysis, only SNRT ≥2128ms was a significant independent predictor of clinical AF recurrence (hazard ratio 7.48; 95% confidence interval 2.94-19.00; P<0.001). Kaplan-Meier estimator showed that the recurrence-free rate was significantly lower if ≥ 2128ms (log-rank, p<0.001). Thirty-five patients (77.8%) underwent a second ablation. Although there was no difference in the rate of pulmonary vein reconnections (78.6% vs. 71.4%, p = 0.712), non-PV triggers were observed more frequently in the longer SNRT group (57.1% vs. 14.3%, p = 0.012)., Conclusions: Patients with a prolonged SNRT had a higher prevalence of AF recurrence after the first ablation and higher inducibility of non-PV triggers. Measuring SNRT might be used for the stratification of patients with persistent AF., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
45. Anticoagulant Therapy for Cancer-Associated Venous Thromboembolism after Cancer Remission.
- Author
-
Hara N, Lee T, Mitsui K, Nagase M, Okata S, Nitta G, Kaneko M, Nagata Y, Nozato T, and Ashikaga T
- Abstract
Objectives: To examine the outcomes of anticoagulant therapy for patients with venous thromboembolism (VTE) with active cancer and the outcomes after cancer remission with and without anticoagulant therapy. Materials and Methods: Of the 338 patients with cancer-associated VTE who received anticoagulant therapy, we evaluated therapeutic outcomes over 1 year for 112 patients whose cancers were in remission (cancer remission group) and 226 patients who continued cancer treatment (continued cancer treatment group). Further, the cancer remission group was divided into 89 and 23 patients who completed (completion of anticoagulation group) and continued (continued anticoagulation group) anticoagulant therapy, respectively. Treatment outcomes after completing anticoagulant therapy were compared between these two groups. The follow-up period was 1 year, and the endpoints were all-cause death, VTE recurrence, and bleeding events. Results: The event-free survival rates were 99.1% and 42.9% in the cancer remission and continued cancer treatment groups, respectively. For treatment outcomes after the completion of anticoagulant therapy, the event-free survival rates were 98.9% and 87% in the completion of anticoagulation and continued anticoagulation groups, respectively (log rank, P=0.005). Conclusion: When cancer is in remission, recurrence is low even if anticoagulant therapy is terminated after a certain period., Competing Interests: Disclosure StatementThe authors declare that there are no conflicts of interest., (© 2021 The Editorial Committee of Annals of Vascular Diseases.)
- Published
- 2021
- Full Text
- View/download PDF
46. Acute Ischemic Mitral Regurgitation Treated by Percutaneous Coronary Intervention after an Accurate Diagnosis on Transesophageal Echocardiography.
- Author
-
Miyazaki R, Watanabe K, Kaneko M, Nagamine S, Hara N, Nakamura T, Nagata Y, Nozato T, and Ashikaga T
- Subjects
- Aged, 80 and over, Echocardiography, Transesophageal, Female, Humans, Mitral Valve diagnostic imaging, Mitral Valve surgery, Papillary Muscles diagnostic imaging, Mitral Valve Insufficiency diagnostic imaging, Mitral Valve Insufficiency surgery, Percutaneous Coronary Intervention
- Abstract
An 80-year-old woman with acute posterolateralmyocardial infarction, cardiogenic shock, and acute heart failure was admitted to our hospital. Transthoracic echocardiography (TTE) showed dysfunction of the left ventricular inferolateral wall motion and severe mitral valve regurgitation (MR). Emergency coronary angiography revealed triple-vessel stenosis. We performed transesophageal echocardiography in the catheter room to diagnose the cause of MR. Severe tenting of the mitral valve and no rupture of the papillary muscles were revealed. We considered ischemic MR likely to improve with revascularization and performed percutaneous coronary intervention. Subsequently, the patient's circulatory dynamics rapidly stabilized, and MR was significantly improved on follow-up TTE.
- Published
- 2021
- Full Text
- View/download PDF
47. Effect of Endovascular Treatment on Systemic Vascular Resistance in Patients with Lower-Limb Peripheral Artery Disease.
- Author
-
Nomoto H, Nozato T, Yamashita S, Suzuki M, Sugiyama T, Oumi T, Ohno M, Shimizu S, Ashikaga T, and Satoh Y
- Abstract
Objective: Endovascular treatment (EVT) for lower-limb peripheral artery disease patients reduces blood pressure (BP) and improves prognosis. This study retrospectively examined hemodynamics during EVT to clarify the mechanism. Materials and Methods: Systemic vascular resistance (SVR) was measured using a noninvasive continuous cardiac output monitoring system during EVT. Furthermore, ankle brachial index was measured before and after EVT. Results: The study included 88 lesions of 56 patients (hypertension in 98%). SVR significantly decreased from 2409.1±746.8 dynes·s·cm
-5 to 2033.7±635.0 dynes·s·cm-5 (p<0.0001). The difference in SVR before and after EVT was significantly greater in the Fontaine IV group than in the Fontaine IIa group (554.7±406.6 dynes·s·cm-5 vs. 312.9±245.7 dynes·s·cm-5 , p=0.0151). The change in SVR was correlated with a change in mean BP in the upper limb (p=0.0026). When the change in pressure gradient between the upper limb and the diseased lower limb was large, mean BP of the upper limb significantly decreased (p=0.0022). Conclusion: EVT can reduce SVR and BP by canceling the pressure gradient between central BP and diseased lower-limb BP., Competing Interests: Disclosure StatementAll authors have no conflict of interest., (© 2020 The Editorial Committee of Annals of Vascular Diseases.)- Published
- 2020
- Full Text
- View/download PDF
48. Administration of Direct Oral Anticoagulant Immediately after Unfractionated Heparin Bolus for the Treatment of Intermediate-High-Risk Pulmonary Thromboembolism.
- Author
-
Hara N, Watanabe K, Miyazaki R, Nakamura T, Lee T, Nagata Y, Nozato T, Miyamoto T, Obayashi T, and Ashikaga T
- Abstract
Objective : This study aims to evaluate the efficacy and safety of direct oral anticoagulants (DOACs) after unfractionated heparin (UFH) bolus for the treatment of intermediate-high-risk pulmonary embolism. Materials and Methods : On the basis of initial treatment, 81 patients were divided into two groups: DOAC after UFH bolus infusion group (group D; n=32) and conventional therapy group (group C; n=49). The frequency of recurrence of venous thromboembolism (VTE) and bleeding within 6 months were compared. In addition, hospitalization length and thrombus reduction rate in the pulmonary artery on computed tomography (CT) at the chronic phase were assessed. Results : Recurrence of VTE was found in one (3.1%) and three patients (6.1%) (P=1.00) in groups D and C, respectively, whereas no bleeding events was found in group D and 8.2% of patients in group C (P=0.15). Group D showed shorter hospitalization (7.2±2.3 days) than group C (15.7±9.9 days; P<0.001). In the subset of patients with serial CT assessment (group D, n=20; group C, n=38), almost all thrombus of pulmonary artery were disappeared and the thrombus reduction rates were similar between the two groups (group D, 99.5%; group C, 97.1%; P=0.59). Conclusion : DOAC administration immediately after UFH bolus treatment has the same efficacy and safety, whereas hospitalization days were significantly shorter than the conventional treatment group., Competing Interests: Disclosure StatementThe authors declare that there is no conflict of interest., (© 2020 The Editorial Committee of Annals of Vascular Diseases.)
- Published
- 2020
- Full Text
- View/download PDF
49. Prediction of premature ventricular complex origins using artificial intelligence-enabled algorithms.
- Author
-
Nakamura T, Nagata Y, Nitta G, Okata S, Nagase M, Mitsui K, Watanabe K, Miyazaki R, Kaneko M, Nagamine S, Hara N, Lee T, Nozato T, Ashikaga T, Goya M, and Sasano T
- Abstract
Background: Catheter ablation is a standard therapy for frequent premature ventricular complex (PVCs). Predicting their origin from a 12-lead electrocardiogram (ECG) is crucial but it requires specialized knowledge and experience., Objective: The objective of the present study was to develop and evaluate machine learning algorithms that predicted PVC origins from an ECG., Methods: We developed the algorithms utilizing a support vector machine (SVM) and a convolutional neural network (CNN). The training, validating, and testing data consisted of 116 PVCs from 111 patients who underwent catheter ablation. The ECG signals were labeled with the PVC origin, which was confirmed using a 3-dimensional electroanatomical mapping system. We classified the origins into 4 groups: right or left, outflow tract, or other sites. We trained and evaluated the model performance. The testing datasets were also evaluated by board-certified electrophysiologists and an existing classification algorithm. We also developed binary classification models that predicted whether the origin was on the right or left side of the heart., Results: The weighted accuracies of the 4-class classification were as follows: SVM 0.85, CNN 0.80, electrophysiologists 0.73, and existing algorithm 0.86. The precision, recall, and F
1 in the machine learning models marked better than physicians and comparable to the existing algorithm. The SVM model scored among the best accuracy in the binary classification (the accuracies were 0.94, 0.87, 0.79, and 0.90, respectively)., Conclusion: Artificial intelligence-enabled algorithms that predict the origin of PVCs achieved superior accuracy compared to the electrophysiologists and comparable accuracy to the existing algorithm., (© 2020 Heart Rhythm Society.)- Published
- 2020
- Full Text
- View/download PDF
50. Comparison of Neointimal Response between Durable-Polymer Everolimus-Eluting Stent and Bioabsorbable-Polymer Everolimus-Eluting Stent for Severely Calcified Lesions Requiring Rotational Atherectomy.
- Author
-
Matsuda Y, Ashikaga T, Sasaoka T, Hatano Y, Umemoto T, Lee T, Yonetsu T, Maejima Y, and Sasano T
- Subjects
- Aged, Aged, 80 and over, Antineoplastic Agents administration & dosage, Everolimus administration & dosage, Female, Humans, Male, Middle Aged, Polymers, Retrospective Studies, Tomography, Optical Coherence, Absorbable Implants statistics & numerical data, Atherectomy, Coronary instrumentation, Drug-Eluting Stents statistics & numerical data, Neointima prevention & control
- Abstract
Clinical outcomes after percutaneous coronary intervention (PCI) for severely calcified lesions remain poor. The purpose of this study was to investigate the neointimal response after everolimus-eluting stents (EES) for severely calcified lesions treated with rotational atherectomy (RA) using optical coherence tomography (OCT).We retrospectively analyzed 34 lesions in which PCI was performed with EES deployment following RA and OCT was performed immediately after PCI and at follow-up (nine months). The EES was either durable-polymer (DP) EES (22 lesions) or bioabsorbable polymer (BP) -EES (12 lesions). Strut coverage and malapposition were evaluated at 1-mm intervals of cross-section (CS) by serial OCT analysis. Malapposed strut was defined as having the distance from luminal border > 100 μm.A total of 11,823 struts immediately after PCI and 11,720 struts at follow-up were analyzed. Immediately after PCI, the strut-level analysis showed no significant differences in the percentage of malapposed struts between the DP-EES group and the BP-EES group. At follow-up, the BP-EES group showed a more prevalent covered strut compared with the DP-EES group (strut-level analysis: 95% versus 97%, P = 0.045; CS-level analysis: 97% versus 100%, P < 0.01; lesion-level analysis: 27% versus 83%, P < 0.01, respectively).In severely calcified lesions requiring RA, the BP-EES group achieved better neointimal coverage than the DP-EES group at nine months. Additional prospective studies are needed.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.